Donmienne Leung
InvestorDirector II, Head of AbbVie Ventures Europe at AbbVie · CEO at ThirtyFiveBio Limited
Oxford, England, United Kingdom
Find your path to Donmienne
196 people in our graph share verified history with Donmienne — schools, employers, funds. One of them is your warm intro.
About
Donmienne Leung leads a dedicated European venture mandate and, after 20+ years as a drug hunter and PhD medicinal chemist with active publications, provides hands-on scientific guidance to biotech boards.
Invests in
AI & Machine LearningBiotechData & InfrastructureHealthtech
CEO at ThirtyFiveBio Limited
Intro paths
In turn, Donmienne can intro founders to ThirtyFiveBio Limited's investors below.
ThirtyFiveBio Limited's investors · 1
Experience
- AbbVieDirector II, Head of Ventures Europecurrent2025 — presentOxford
- AbbVieDirector, AbbVie Ventures UK/Europe2023 — 2025Oxford, England, United Kingdom
- ThirtyFiveBioBoard Membercurrent2025 — present
- CephagenixBoard Membercurrent2025 — presentParis and Copenhagen
- EvolveImmune TherapeuticsBoard Membercurrent2024 — presentBranford, Connecticut, United States
- Endlyz TherapeuticsBoard Membercurrent2023 — presentOxford, England, United Kingdom
- Enthera PharmaceuticalsBoard Observer2023 — 2025Milan, Lombardy, Italy
- DISCO Pharmaceuticals GmbHBoard Observer2023 — 2025Cologne, North Rhine-Westphalia, Germany
- Absolute BiotechHead of Protein Engineering2021 — 2023Redcar
- Eli Lilly and CompanySenior Research Advisor2020 — 2021
- Eli Lilly and CompanyResearch Advisor2017 — 2020Greater San Diego Area
- Eli Lilly and CompanyPrinicipal Research Scientist2012 — 2017
- Eli Lilly and CompanySenior Research Scientist2008 — 2012
- Eli Lilly and CompanyResearch Scientist2005 — 2008
- The Scripps Research InstitutePostdoctoral Scientist2001 — 2005San Diego, California, United States
- University of QueenslandPHD Student1997 — 2001Brisbane, Australia
- University of MelbourneHonors Student1996 — 1997Melbourne, Victoria, Australia
- Walter and Eliza Hall Institute of Medical ResearchResearch Assistant1994 — 1996Melbourne, Victoria, Australia
Skills & more
+12 more
HPLCDrug DevelopmentMedicinal ChemistryCell BiologyCell CultureBiotechnologyImmunologyELISAChromatographyWestern BlottingVolunteeringDrug DesignLanguages Chinese · English
- VC University — VC University
From Donmienne's professional profile.
Colleagues at AbbVie
Frequently asked questions
- Who is Donmienne Leung?
- Donmienne Leung leads a dedicated European venture mandate and, after 20+ years as a drug hunter and PhD medicinal chemist with active publications, provides hands-on scientific guidance to biotech boards.
- Where does Donmienne Leung work?
- Donmienne Leung is Director II, Head of AbbVie Ventures Europe at AbbVie and CEO at ThirtyFiveBio Limited.
- What does Donmienne Leung invest in?
- Donmienne Leung invests in AI & Machine Learning, Biotech, Data & Infrastructure, Healthtech.
- Where did Donmienne Leung go to school?
- Donmienne Leung studied at The University of Queensland (Doctor, Philosophy); University of Melbourne (Bachelor of Science (Honours), Chemistry / Biochemistry); University of Melbourne (Bachelor of Science & Bachelor of Engineering, Biochemistry).
Founder mafias
University of Melbourne mafia97
Also came through, then founded or led a company.
+ 90 more
AbbVie mafia13
Also came through, then founded or led a company.
+ 6 more
Enthera mafia2
Also came through, then founded or led a company.
Same school
Also attended The University of Queensland184
+ 178 more
Also attended University of Melbourne342
+ 336 more
Shared employers
Also worked at AbbVie44
+ 38 more
Also worked at Enthera Pharmaceuticals4
Also worked at DISCO Pharmaceuticals GmbH3
Also worked at Eli Lilly and Company120
+ 114 more

































:format(webp)/f/174198/3860x2650/d857c55b6f/steel-blue-clarissa.png)










